FailedFiled Jan 21, 2026
Sponsor: Steinborn, Jeff
Latest Action
Action Postponed Indefinitely (session adjourned sine die)
Feb 19, 2026
Summary
The bill lets people with life‑threatening or severely disabling illnesses ask manufacturers for personalized investigational drugs or devices made to match their genetic profile. Patients must give detailed written consent and may be charged for the treatment, while insurers are not required to pay for it. The law also protects patients’ estates from debt and shields doctors from discipline for recommending such treatments.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 33 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 33 freeOr ask your AI assistant about SB 33 directly:
Add to Claude, ChatGPT or Cursor